Holen Sie sich die Stockscreener-App
0.57
6.56%
-0.04
Schlusskurs vom Vortag:
$0.61
Offen:
$0.591
24-Stunden-Volumen:
19,507
Relative Volume:
0.66
Marktkapitalisierung:
$3.65M
Einnahmen:
$1.10M
Nettoeinkommen (Verlust:
$-17.48M
KGV:
-0.1672
EPS:
-3.4099
Netto-Cashflow:
$-9.01M
1W Leistung:
-4.20%
1M Leistung:
-5.41%
6M Leistung:
-69.68%
1J Leistung:
+1.71%
1-Tages-Spanne:
$0.57
$0.636
1-Wochen-Bereich:
$0.5603
$0.6559
52-Wochen-Spanne:
$0.4748
$3.09
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
Firmenname
Matinas Biopharma Holdings Inc
Sektor
Branche
Telefon
908-443-1860
Adresse
1545 Route 206 South, Suite 302, Bedminster, NJ
Compare MTNB vs VRTX, REGN, ALNY, ARGX, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
0.57 | 3.91M | 1.10M | -17.48M | -9.01M | -3.4099 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-05-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-08-26 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-01-27 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-24 | Eingeleitet | SunTrust | Buy |
| 2020-01-23 | Eingeleitet | SunTrust | Buy |
| 2020-01-09 | Eingeleitet | Aegis Capital | Buy |
| 2019-06-26 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Matinas Biopharma Holdings Inc Aktie (MTNB) Neueste Nachrichten
Volume Recap: Will Matinas BioPharma Holdings Inc outperform tech stocks2026 Fed Impact & AI Enhanced Trading Signals - baoquankhu1.vn
MTNB PE Ratio & Valuation, Is MTNB Overvalued - Intellectia AI
Aug Update: Is Matinas BioPharma Holdings Inc a stock for growth or value investors2026 Pullback Review & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Performance Recap: What are the future prospects of Matinas BioPharma Holdings Inc2026 Momentum & Breakout Confirmation Trade Signals - baoquankhu1.vn
Volume Recap: Whats the beta of Matinas BioPharma Holdings Inc stockTrade Exit Report & Low Risk High Win Rate Picks - baoquankhu1.vn
MTNB Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Dow Update: Can Matinas BioPharma Holdings Inc keep up with sector leaders2026 Technicals & Fast Entry and Exit Trade Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Gainers Report: How does ATHPRC correlate with NasdaqSwing Trade & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Can Matinas BioPharma Holdings Inc. ride the EV waveJuly 2025 Review & Risk Managed Trade Strategies - Mfd.ru
Is Matinas BioPharma Holdings Inc. a stock for growth or value investorsJuly 2025 Recap & Safe Capital Growth Tips - mfd.ru
Why Matinas BioPharma Holdings Inc. (6LJ0) stock is favored by hedge fundsWeekly Stock Report & High Accuracy Investment Signals - mfd.ru
Can Matinas Biopharma Holdings Inc. stock survive global slowdownWeekly Investment Report & Consistent Growth Stock Picks - mfd.ru
Entry Recap: Is Matinas BioPharma Holdings Inc exposed to currency risksJuly 2025 Catalysts & Weekly Breakout Watchlists - baoquankhu1.vn
What are the future prospects of Matinas BioPharma Holdings Inc.Trade Risk Summary & Smart Allocation Stock Tips - mfd.ru
What is Matinas BioPharma Holdings Inc. s P E ratio telling us2025 Biggest Moves & Safe Entry Zone Identification - mfd.ru
Can Matinas BioPharma Holdings Inc. stock outperform in 2025 bull market2025 Key Lessons & Weekly High Return Forecasts - mfd.ru
Merger Talk: Can Matinas BioPharma Holdings Inc ride the EV waveTrade Performance Summary & High Conviction Trade Alerts - baoquankhu1.vn
Matinas BioPharma appoints CEO Jerome Jabbour as interim CFO By Investing.com - Investing.com Nigeria
Matinas BioPharma CEO Named Interim Chief Financial Officer - The Globe and Mail
Matinas BioPharma appoints CEO Jerome Jabbour as interim CFO - Investing.com
Matinas BioPharma Holdings Inc Keith Kucinski resigns as CFO effective January 17, 2026 - marketscreener.com
Buyback Watch: Is STNG undervalued by DCF analysisBuy Signal & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Matinas Biopharma Holdings Inc Keith Kucinski Resigns As CFO Effective January 17, 2026 - TradingView
Trend Report: Is Matinas BioPharma Holdings Inc stock heavily shortedNew Guidance & Weekly High Conviction Ideas - baoquankhu1.vn
Valuation Update: What is CRVSs book value per share2025 Year in Review & Daily Market Momentum Tracking - baoquankhu1.vn
Exit Recap: Is Matinas BioPharma Holdings Inc stock heavily shortedJuly 2025 Short Interest & Weekly High Return Stock Opportunities - baoquankhu1.vn
Sectors Review: Will Mega Matrix Inc stock maintain momentum in 2025Weekly Risk Summary & Verified Chart Pattern Trade Signals - Bộ Nội Vụ
MSN Money - MSN
Will Matinas Biopharma Holdings Inc. stock announce special dividend2025 Market Sentiment & AI Forecasted Stock Moves - Улправда
How Matinas Biopharma Holdings Inc. stock trades pre earningsJuly 2025 Chart Watch & Long Hold Capital Preservation Tips - ulpravda.ru
How Matinas BioPharma Holdings Inc. stock performs in weak economyEarnings Risk Summary & Consistent Growth Equity Picks - ulpravda.ru
2026 world cup canada qualification young talents counter attacking knockout prediction insights2025 Risk Factors & Fast Gain Swing Alerts - Улправда
2026 world cup canada quarterfinals best goals insightsMarket Performance Summary & Free Accurate Trade Setup Notifications - Улправда
Is Sprout Social Inc. stock a dividend growth opportunityMarket Performance Report & Technical Analysis for Trade Confirmation - Улправда
Will Enpro Inc. stock attract ESG investorsQuarterly Market Review & Community Trade Idea Sharing - ulpravda.ru
Will Matinas BioPharma Holdings Inc. stock reach all time highs in 2025 - Улправда
Will Matinas BioPharma Holdings Inc. stock deliver strong dividend growth2025 Breakouts & Breakdowns & Smart Investment Allocation Tips - ulpravda.ru
How currency fluctuations impact Toppoint Holdings Inc. stockQuarterly Portfolio Summary & Reliable Breakout Stock Forecasts - ulpravda.ru
Will Matinas BioPharma Holdings Inc. stock outperform growth indexesQuarterly Trade Summary & Free Reliable Trade Execution Plans - Улправда
2026 world cup usa round of 32 defensive leaders set piece tactics match prediction insightsInflation Watch & Weekly Watchlist for Hot Stocks - Улправда
Analyst Upgrade: Is Matinas BioPharma Holdings Inc. stock a defensive play in 20252025 Fundamental Recap & Weekly Chart Analysis and Trade Guides - Bộ Nội Vụ
US Market Wrap: Will Wetouch Technology Inc stock rally after Fed decisions2025 Year in Review & High Accuracy Swing Entry Alerts - moha.gov.vn
Ventive Hospitality Limited Building a Base Near SupportMACD Histogram Signals & Avoid Market Traps With Pro-Level Warnings - bollywoodhelpline.com
Indrayani Biotech Limited Recovery Gathers Momentum on Chart SignalsInflation Impact on Stocks & Breakout Portfolio Performance - bollywoodhelpline.com
Is Now a Good Time to Reenter Relic Technologies LimitedInstitutional Buying Trends & Low Entry Cost Trading - bollywoodhelpline.com
Is It Too Late to Sell TCM LimitedDividend Stability Analysis & Free Dynamic Capital Growth - bollywoodhelpline.com
Holdings Limited RecoverySwing Trading Watchlist & Free Navigate Market With Precision - bollywoodhelpline.com
Will Matinas BioPharma Holdings Inc. (6LJ0) stock sustain uptrend momentumPortfolio Return Report & High Conviction Investment Ideas - Улправда
Can Matinas BioPharma Holdings Inc. stock beat market expectations this quarter2025 Big Picture & Verified Trade Idea Suggestions - Улправда
Breakout Watch: Can Matinas BioPharma Holdings Inc. stock beat market expectations this quarterPortfolio Performance Report & Capital Efficiency Focused Ideas - Улправда
Finanzdaten der Matinas Biopharma Holdings Inc-Aktie (MTNB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):